Skip to content

Drug interactions

Fedratinib + Netupitant-palonosetron

Severity: Moderate

Fedratinib and Netupitant-palonosetron: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fedratinib is a moderate CYP3A4 inhibitor and may modestly raise netupitant concentrations. Netupitant, being a CYP3A4 inhibitor itself, may also affect fedratinib, which is a CYP3A4 substrate, raising fedratinib exposure and toxicity such as GI effects and encephalopathy risk.

What this interaction means in plain words

Fedratinib and Netupitant-palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Fedratinib belongs to Oncology; Netupitant-palonosetron belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Mutual CYP3A4 inhibition affecting metabolism of both netupitant and fedratinib.

What to do

Monitor for adverse effects of both drugs; consider reducing fedratinib dose per its labeling for CYP3A4 inhibitors if repeated netupitant dosing is used.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fedratinib and Netupitant-palonosetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fedratinib with Netupitant-palonosetron?

MediHelp rates the interaction as moderate. Fedratinib and Netupitant-palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Fedratinib is a moderate CYP3A4 inhibitor and may modestly raise netupitant concentrations. Netupitant, being a CYP3A4 inhibitor itself, may also affect fedratinib, which is a CYP3A4 substrate, raising fedratinib exposure and toxicity such as GI effects and encephalopathy risk.

How serious is the interaction between Fedratinib and Netupitant-palonosetron?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for adverse effects of both drugs; consider reducing fedratinib dose per its labeling for CYP3A4 inhibitors if repeated netupitant dosing is used.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in